Jacobson Center for Clinical & Translational Research

Main Menu

/research/

Additional Information

 

Contact Us

Prostate Cancer Research

Study Title:  RTOG 0924: Androgen Deprivation Therapy and High Dose Radiotherapy with or without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer:  A Phase III Randomized Trial (Identifier: NCT01368588)

Principal Investigator: Krishna Reddy, M.D.

Study Purpose:  This randomized phase III trial studies androgen-deprivation therapy and radiation therapy in treating patients with prostate cancerAndrogens can cause the growth of prostate cancer cells. Androgen deprivation therapy may stop the adrenal glands from making androgens. Radiation therapy uses high-energy x-rays to kill tumor cells.

Study Coordinator:  For more information email Stephanie Smiddy, RN or call 419.383.6962.


 

Last Updated: 4/26/18